Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Flerie AB | 792,000 | net | 05 Feb 2021 | tx 4+792,000 |
| Medivir AB | 80,000 | net | 21 Dec 2023 | tx 7+80,000 |
| Cinclus Pharma Holding AB (publ) | 60,771 | net | 20 Jun 2024 | tx 3+60,771 |
| Calliditas Therapeutics ab | 30,000 | net | 17 Feb 2020 | tx 4+30,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Jun 2024 | PURCHASE | Cinclus Pharma Holding AB (publ) | 28,530 | 40.00 SEK | |
| 20 Jun 2024 | PURCHASE | Cinclus Pharma Holding AB (publ) | 19,170 | 42.00 SEK | |
| 20 Jun 2024 | PURCHASE | Cinclus Pharma Holding AB (publ) | 13,071 | 42.00 SEK | |
| 21 Dec 2023 | PURCHASE | Medivir AB | 20,000 | 2.65 SEK | first after silence |
| 05 Feb 2021 | PURCHASE | Flerie AB | 360,000 | 1.20 SEK | |
| 05 Feb 2021 | OTHER | Flerie AB | 360,000 | 0.00 SEK | deriv |
| 03 Feb 2021 | PURCHASE | Medivir AB | 10,000 | 7.00 SEK | |
| 03 Feb 2021 | PURCHASE | Medivir AB | 10,000 | 0.00 SEK | deriv |
| 17 Feb 2020 | PURCHASE | Calliditas Therapeutics ab | 3,000 | 112.00 SEK | |
| 20 Sept 2019 | PURCHASE | Flerie AB | 42,000 | 7.20 SEK | |
| 15 Feb 2019 | PURCHASE | Medivir AB | 10,000 | 22.26 SEK | |
| 05 Nov 2018 | PURCHASE | Calliditas Therapeutics ab | 9,000 | 44.00 SEK | |
| 05 Nov 2018 | PURCHASE | Calliditas Therapeutics ab | 9,000 | 44.00 SEK | |
| 17 May 2018 | PURCHASE | Flerie AB | 30,000 | 6.19 SEK |
1 purchase reported after at least 12 months of silence — most recent on 21 Dec 2023.